Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | SRC | P12931 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4774509 | 0.78 | DPP4 (0.45) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL1494253 | 0.75 | DPP4 (0.43) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL2796779 | 0.73 | DPP4 (0.41) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL245489 | 0.73 | TSHR (0.48) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL842214 | 0.73 | DPP4 (0.41) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL10768536 | 0.73 | DPP4 (0.41) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL704608 | 0.73 | DPP4 (0.41) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL8386068 | 0.73 | DPP4 (0.41) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL8381565 | 0.73 | DPP4 (0.41) | DPP4F2TSHRHTR2ATAAR1 | |
| SCHEMBL434195 | 0.73 | SRC (0.42) | DPP4F2TSHRCYP2D6SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230405155-A1 | NANOPARTICLE, PHOTOACOUSTIC CONTRAST AGENT, PHOTODYNAMIC THERAPY DRUG, AND PHOTOTHERMAL THERAPY DRUG | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-12-21 | — | — | US | disclosed |
| EP-4241846-A1 | NANOPARTICLES, PHOTOACOUSTIC CONTRAST AGENT, PHOTODYNAMIC THERAPEUTIC AGENT, AND PHOTOTHERMAL THERAPEUTIC AGENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-09-13 | — | — | EP | disclosed |
| CN-110741028-B | Method for producing polymer compound | 住友化学株式会社 | 2022-05-03 | — | — | CN | disclosed |
| EP-3442045-B1 | ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND SOLAR BATTERY MODULE AND SENSOR PROVIDED WITH SAME | SUMITOMO CHEMICAL CO (JP) | 2022-01-12 | — | — | EP | disclosed |
| US-11063219-B2 | Organic photoelectric conversion element, and solar cell module and sensor provided with the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-07-13 | — | — | US | disclosed |
| US-10777746-B2 | Compound and electronic device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-09-15 | — | — | US | disclosed |
| CN-110741028-A | Method for producing polymer compound | 住友化学株式会社 | 2020-01-31 | — | — | CN | disclosed |
| US-10290809-B2 | Macromolecular compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-05-14 | — | — | US | disclosed |
| US-20190115540-A1 | ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND SOLAR CELL MODULE AND SENSOR PROVIDED WITH THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-04-18 | — | — | US | disclosed |
| EP-3442045-A1 | ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND SOLAR BATTERY MODULE AND SENSOR PROVIDED WITH SAME | Sumitomo Chemical Company, Limited (JP) | 2019-02-13 | — | — | EP | disclosed |
| EP-2128168-A1 | METAL COMPLEX, POLYMER COMPOUND AND DEVICE CONTAINING THOSE | Sumitomo Chemical Company, Limited (JP) | 2009-12-02 | — | — | EP | disclosed |
| US-20090039765-A1 | LIGHT EMITTING POLYMER COMPOSITION AND POLYMER LIGHT EMITTING DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-02-12 | — | — | US | disclosed |
| US-20090043064-A1 | METAL COMPLEX, POLYMER COMPOUND, AND DEVICE CONTAINING IT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-02-12 | — | — | US | disclosed |
| EP-1932851-A1 | METAL COMPLEX, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING DEVICE | Sumitomo Chemical Company, Limited (JP) | 2008-06-18 | — | — | EP | disclosed |
| US-20080138651-A1 | Polyanilines; strong fluorescence and large charge transporting properties | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-06-12 | — | — | US | disclosed |
| US-20080003422-A1 | Polymer Compound, Polymer Thin Film and Polymer Thin Film Device Using the Same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-01-03 | — | — | US | disclosed |
| US-20070063190-A1 | Aromatic compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-03-22 | — | — | US | disclosed |
| US-20070051922-A1 | Polymer light-emitting material and polymer light-emitting device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-03-08 | — | — | US | disclosed |
| US-20070020479-A1 | Luminescent-polymer composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-01-25 | — | — | US | disclosed |
| EP-1571170-A1 | HIGH-MOLECULAR COMPOUNDS AND POLYMER LIGHT EMITTING DEVICES MADE BY USING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2005-09-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090039765-A1 | LIGHT EMITTING POLYMER COMPOSITION AND POLYMER LIGHT EMITTING DEVICE | CYBA, BCAT1, CRY1 | DPP4 4700/4885F2 1485/4885TSHR 4076/4885 |
| US-20230405155-A1 | NANOPARTICLE, PHOTOACOUSTIC CONTRAST AGENT, PHOTODYNAMIC THERAPY DRUG, AND PHOTOTHERMAL THERAPY DRUG | CRY2, RB1, NR2E3 | DPP4 4493/4885F2 1682/4885TSHR 331/4885 |
| US-10290809-B2 | Macromolecular compound | EXOSC4, TRPC6, MRPS22 | DPP4 4505/4885F2 2556/4885TSHR 1066/4885 |
| US-20080138651-A1 | Polyanilines; strong fluorescence and large charge transporting properties | BRS3, SLC43A1, MRPS23 | DPP4 4228/4885F2 1765/4885TSHR 1412/4885 |
| US-20070063190-A1 | Aromatic compound | AHR, AR, NR0B1 | DPP4 2371/4885F2 989/4885TSHR 1227/4885 |
| US-20090043064-A1 | METAL COMPLEX, POLYMER COMPOUND, AND DEVICE CONTAINING IT | TIMCC, AP1M1, TXN | DPP4 4821/4885F2 6/4885TSHR 3303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.